<DOC>
	<DOCNO>NCT00856362</DOCNO>
	<brief_summary>The purpose study evaluate effect single dos midazolam plasma concentration single dose moxidectin healthy young adult subject , assess safety co-administration moxidectin midazolam .</brief_summary>
	<brief_title>Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Milbemycin</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Inclusion criterion : 1 . Men woman nonchildbearing potential ( WONCBP ) age 18 50 year inclusive screening . WONCBP may include either surgically sterile ( hysterectomy and/or oophorectomy ) postmenopausal ≥1 year ( folliclestimulating hormone [ FSH ] ≥38 mIU/mL ) must negative pregnancy test result within 48 hour administration test article . Women surgically sterile must provide documentation procedure operative report ultrasound . Sexually active men must agree use medically acceptable form contraception study continue 12 week test article administration . 2 . Body mass index range 18 30 kg/m2 body weight ≥50 kg . 3 . Healthy determine investigator basis screen evaluation . Exclusion criterion : 1 . Women childbearing potential . 2 . Presence history disorder may prevent successful completion study . 3 . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>